Shares of CRISPR Therapeutics AG (CRSP) have gained more than 40% over the past three months against the industry’s decline of nearly 11%. Moreover, the stock has surged more than 80% over the past month. The gene-editing stock continues to enjoy accelerated momentum from a key regulatory approval. On November 16, CRISPR Therapeutics and its partner, Vertex Pharmaceuticals Incorporated (VRTX), […]

Throughout 2023, the U.S. stock market experienced several micro-cycles. From January to July, the SPDR S&P 500 ETF Trust (SPY), which tracks the performance of the S&P 500 index, advanced over 19% on a total return basis. However, in late October, nearly half that momentum had withered, with the Index briefly plunging into correction territory, indicating a 10% […]

Despite macroeconomic concerns, auto sales are expected to increase due to pent-up demand and technological advancements. Therefore, it could be wise for investors to buy fundamentally sound auto stock Volkswagen AG (VWAGY – Get Rating) now. However, I think NIO Inc. (NIO – Get Rating) could be best avoided, given its weak financials. In October, new vehicle sales in […]

Management fees are an essential aspect of investing in a mutual fund and some may sometimes remain hidden to investors that don’t know to look for them when picking which fund is right for them. These fees cover the cost of managing the fund’s assets and pay for the expertise provided by professional money managers. […]

Longshots. Have you ever had one off big for you? Years ago, I had a friend who took some time off to travel around the country on his motorcycle. After a few months, he left Denver and was riding the backroads headed back East. He wanted to explore the West Coast, but he was low […]